Tetanus/Diphtheria Vaccine In Shortage; CDC Prioritizes Travel Immunizations
Executive Summary
Adult tetanus/diphtheria vaccine is in short supply following cessation of manufacturing by Wyeth-Ayerst and retooling of a plant by Aventis.
You may also be interested in...
Wyeth Will Lose 18.5% Of Marietta Sales If Firm Does Not Comply With GMPs
Wyeth-Ayerst would have to pay the government 18.5% of future net sales from products manufactured at its Marietta, Penn. facility if it fails to meet a timeline for bringing the plant into compliance with current Good Manufacturing Practices under an Oct. 3 consent decree with FDA.
FDA Concerned By Shrinking Vaccine Supplier Pool, CBER's Zoon Says
The potential for vaccine manufacturers to exit the business is "very troubling" to FDA, Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, told the Regulatory Affairs Professionals Society annual meeting in Washington, D.C. Oct. 4.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011